Pharma Tariffs: Analysis of Trump's 100% Duties on Branded Drugs

New Tariffs on Pharmaceuticals

• 🎯 President Trump has announced new duties, including 100% tariffs on branded drugs and 25% on heavy-duty trucks.
• 📉 These measures have already led to falls in share prices for pharmaceutical companies like AstraZeneca and Novo Nordisk.

Potential Impact on EU Trade

• ❓ There is significant uncertainty regarding the application of these tariffs to US imports from the EU, especially given the existing trade deal.
• 💡 Exemptions may be available for companies investing in the US, which most European pharmaceutical firms do.
• ⚠️ The US may also find that certain medications cannot be produced domestically in sufficient quantities, further complicating the situation.
• 💬 Overall, these tariffs are expected to add to confusion and noise rather than cause a major disruption to trade.

Geopolitical Considerations and Trade Deals

• 🤝 The EU must accept the Trump administration as an unreliable partner and work with it for geopolitical reasons, particularly concerning Russia's aggression in Ukraine.
• 🇪🇺 The current trade deal between the EU and US is asymmetric, with the EU reducing tariffs while the US maintains higher ones.

Future Outlook for Tariffs

• 📈 Uncertainty remains high, with potential for further sectoral tariffs depending on legal rulings and political decisions.
• 📉 The overall negative impact of US tariffs is likely near its peak and may fade from late this year onwards.
• 🗳️ Escalation is unlikely as it could lead to higher consumer prices in the US, negatively impacting upcoming congressional elections.

Investment and Factory Relocation

• 🏭 Some European companies, especially larger ones, may move factories to the US due to these measures.
• 📉 However, many smaller companies may avoid investing in the US due to its unreliability, potentially balancing out major relocation trends.